Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine,
Which COVID vaccine is better? It’s hard to say that one is better than the other. “Antibody studies have shown that the mRNA ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...
A now-defunct Canadian company was trying to produce vaccine components in vegetables, not add vaccines to the produce found ...
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, ...
An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.
Researchers have been working on mRNA flu vaccines since before the Covid-19 pandemic, but we may get one for bird flu first.
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback